CIK 0001703057 · Large accelerated filer
AbCellera Biologics Inc.
Sign in to watch- Ticker
- ABCL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- British Columbia, Canada
- Entity type
- operating
- Phone
- (604) 559-9005
- Business address
- 150 W 4TH AVENUE, VANCOUVER, British Columbia, Canada, V5Y 1G6
- Open-market buys, last 90 days
- $1,379,662
- in 3 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$1,379,662. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-09-01 | HAMER JOHN Director | Sale | −137,351 | $16.93 | $2.3M | 128,862 |
| 2021-08-31 | HAMER JOHN Director | Sale | −162,649 | $16.95 | $2.8M | 266,213 |
| 2021-06-22 | Hayden Michael R Director | Sale | −100,000 | $25.50 | $2.5M | 1,003,397 |
| 2021-06-09 | Thermopylae Holdings Ltd. 10% owner | Sale | −5,598,420 | $24.03 | $134.5M | 55,604,330 |
| 2021-06-09 | Hansen Carl L. G. Chief Executive Officer | Sale | −5,598,420 | $24.03 | $134.5M | 55,604,330 |
| 2021-06-09 | Hansen Carl L. G. Chief Executive Officer | Sale | −401,580 | $25.50 | $10.2M | 233,500 |
| 2021-06-09 | Lecault Veronique Chief Operating Officer | Sale | −1,000,000 | $25.50 | $25.5M | 273,630 |
| 2021-06-09 | Stimart Tryn Chief Legal Officer | Sale | −1,000,000 | $25.50 | $25.5M | 250 |
| 2021-06-09 | Booth Andrew Chief Financial Officer | Sale | −1,200,000 | $25.50 | $30.6M | 0 |
| 2021-06-09 | Falconer Ester Chief Technology Officer | Sale | −1,000,000 | $25.50 | $25.5M | 0 |
Page 1 of 1 · 10 trades